Pigmentation & photoprotection
Pre-clinical research has measured eumelanin density and UV-response endpoints following melanocortin agonist administration in female models.
Beauty
MT-2 (Melanotan II)
Melanogenesis research
A synthetic analog of α-MSH studied as a non-selective melanocortin receptor agonist in pigmentation and sexual-function research.
$34.99per vial · research use
Quantity
Up to 50%
- Melanogenesis models
- MC receptor pharmacology
- Photoprotection research
For research use only. Not for human consumption.
Women's research notes
What researchers study MT-2 (Melanotan II) for in women
MT-2 research intersects with female-specific endpoints in dermatology and sexual-function studies, including HSDD (hypoactive sexual desire disorder) — its analog bremelanotide is FDA-approved in premenopausal women.
Female sexual-function research
MC4R agonism is the mechanism underlying bremelanotide, FDA-approved for premenopausal HSDD — MT-2 is the structural parent compound studied in that research lineage.
Appetite & energy balance
Female pre-clinical models have examined melanocortin agonist effects on food intake and energy expenditure endpoints.
Selected literature
- Dorr RT, et al. Life Sci 1996 — Melanotan II pharmacology
- Kingsberg SA, et al. Obstet Gynecol 2019 — Bremelanotide for HSDD
Information below summarizes published pre-clinical and clinical research. It is provided for educational purposes for qualified researchers and is not medical advice, a treatment recommendation, or a claim of efficacy. Products are sold for research use only.
